Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia

A pharmaceutical preparation, polycystic ovary technology, applied in the field of medicine, can solve the problems of the drug for breast hyperplasia and the aggravation of breast hyperplasia, etc.

Inactive Publication Date: 2016-05-04
林立朋
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the prevalence of mammary gland hyperplasia is higher in patients treated with clomiphene, and the menstrual disorders and the use of estrogen-like drugs are positively correlated with mammary gland hyperplasia. These drugs for the treatment of polycystic ovary syndrome can aggravate mammary gland hyperplasia
Therefore, for patients with polycystic ovary syndrome combined with mammary gland hyperplasia, traditional Chinese medicine treatment is the first choice, but there is no drug available for polycystic ovary syndrome combined with mammary gland hyperplasia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia
  • Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia
  • Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Embodiment 1 capsule

[0081] Prescription: 16 parts psoraleae, 12 parts Shayuanzi, 20 parts Ligustrum lucidum, 10 parts carrot, 8 parts Huajuhong, 12 parts Codonopsis, 10 parts Atractylodes macrocephala, 15 parts poria cocos, 15 parts Gonggong leaf, three golden grass 12 servings, 15 servings of Tian Xian Teng, 8 servings of Liu Jinu, 15 servings of Little Red Ginseng, and 8 servings of Passepartout.

[0082] Preparation method: (1) Grind carrot seeds, Huajuhong, Sandianjincao, Tianxianteng, and Liu Jinu, and extract them with 70% ethanol under reflux for 1-3 times, combine the extracts, concentrate under reduced pressure to obtain dilute extracts, and put them on The polyamide column is first eluted with 5% ethanol until the effluent is colorless, and then eluted with 90% ethanol, the ethanol eluate is collected, the ethanol is recovered under reduced pressure until there is no alcohol smell, and the concentration is continued to a thick paste, freeze-dried to obtain ...

Embodiment 2

[0086] Embodiment 2 capsules

[0087] Prescription: 15 parts of psoralen, 15 parts of sand garden seed, 25 parts of privet privet, 12 parts of carrot seed, 6 parts of orange red, 12 parts of codonopsis, 12 parts of Atractylodes macrocephala, 12 parts of poria cocos, 12 parts of Gonggong leaf, three golden grass 10 servings, 15 servings of Tian Xian Teng, 8 servings of Liu Jinu, 12 servings of Little Red Ginseng, and 6 servings of Passepartout.

[0088] Preparation method: carry out with reference to Example 1.

Embodiment 3

[0089] Embodiment 3 capsules

[0090] Prescription: 18 parts of psoralen, 16 parts of sand garden seed, 24 parts of Ligustrum lucidum, 12 parts of carrot seed, 7 parts of Huajuhong, 12 parts of codonopsis, 10 parts of Atractylodes macrocephala, 11 parts of poria cocos, 17 parts of Gonggong leaf, three golden grass 10 servings, 18 servings of Tian Xian Teng, 8 servings of Liu Jinu, 12 servings of Little Red Ginseng, 6 servings of Passepartout.

[0091] Preparation method: carry out with reference to Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines and relates to a pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia and a preparation method thereof. The pharmaceutical preparation is elaborately prepared from the medicinal raw materials including fructus psoraleae, flatstem milkvetch seeds, glossy privet fruits, carrot seeds, exocarpium, pilose asiabell roots, white atractylodes rhizomes, poria cocos, Chinese holly leaves, hedyotis acutangula, herba aristolochiae, a diverse wormwood herb, small red ginsengs and liquidambaris fructus according to a certain weight part proportion. The medicinal raw materials play the effects of tonifying kidney, regualting liver, warm the middle-Jiao, strengthening the spleen, eliminating dampness and phlegm, promoting qi to activate blood, dissipating stasis and relieving pain together. The pharmaceutical preparation treats root causes of kidney deficiency and symptoms of phlegmatic hygrosis and is reasonable in compatibility and plays a multi-target-point multi-link multi-level comprehensive adjustment and control effect, and a clinical application proves that the pharmaceutical preparation has a definite treating effect and is smaller in side effect, better in patient compliance and convenient to take.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a pharmaceutical preparation for treating polycystic ovary syndrome combined with mammary gland hyperplasia and a preparation method thereof. Background technique [0002] Polycystic ovary syndrome (polycysticovarian syndrome, PCOS) is an endocrine syndrome with multifactorial pathogenesis and polymorphic clinical manifestations. Obstetrics and gynecology is a relatively common endocrine disorder in clinical practice, and it is one of the most common causes of menstrual disorders in women of childbearing age in China and even in the world. [0003] Hyperplasia of mammary glands is a disease related to endocrine dysfunction, clinically manifested as periodic or non-periodic breast pain and breast lumps with different manifestations. Histology shows that the number of cells in the parenchyma of the breast tissue increases, and the disorder of the breast structure in different degre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/752A61P15/08A61P15/14A61P5/28
CPCA61K36/487A61K36/076A61K36/185A61K36/23A61K36/264A61K36/282A61K36/284A61K36/29A61K36/344A61K36/48A61K36/481A61K36/638A61K36/74A61K36/752A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/55A61K2300/00
Inventor 林立朋
Owner 林立朋
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com